On May 26th, the China Cardiovascular Health Index 2023 was grandly released at the opening ceremony of the 17th Oriental Congress of Cardiology. The China Cardiovascular Health Index (CHI) is not only the first medical index-type indicator reflecting and measuring the status of cardiovascular diseases and treatment in our country, but also the world’s first comprehensive index assessment of three-dimensional scanning for cardiovascular disease prevention and control at a national level. It holds a milestone significance for the development of cardiovascular disease prevention and treatment.

The data for China Cardiovascular Health Index 2023 is derived from nationwide surveys/monitoring/yearbooks, national research projects, authoritative institutions, and special calculations, comprising a total of 17 authoritative data sources. CHI encompasses 5 major dimensions and 52 indicators, comprehensively reflecting cardiovascular health influencing factors. Over a period of 7 years, it forms a systematic data matrix, providing an in-depth reflection of changes in cardiovascular health index. Covering 31 provinces and municipalities, it generates personalized provincial-level data to accurately portray the strengths and weaknesses of each region’s management.

According to the results released in China Cardiovascular Health Index 2023, Shanghai ranks first nationwide with a total score of 81.59 points, followed by Zhejiang Province (78.60 points), Beijing (77.21 points), Jiangsu Province (73.34 points), Fujian Province (73.29 points), and Hubei Province (66.33 points) in the 2nd to 6th positions, respectively. The national CHI and scores for each dimension have continued to rise from 2017 to 2023, reflecting the enhancement of our country’s cardiovascular disease treatment capabilities and improvements in public health services.

China Cardiovascular Health Index 2023 has undergone four editions of continuous updates since 2017, clearly reflecting the vertical changes of CHI over the years. It is anticipated that CHI will persist in its efforts to promote the early realization of China’s cardiovascular disease health goals.